Study sites
Weill Cornell Medical Center | Cleveland Clinic | Hospital of the University of Pennsylvania
KONECT RESILIA aortic valved conduit
The first real-world multicenter study of bio-Bentall procedures with a novel pre-assembled aortic valved conduit1
Number of patients
329 patients
Aortic valve etiology
Aortic aneurysm, aortic dissection, endocarditis, and valvular dysfunction
Freedom from all-cause mortality at one year
Freedom from cardiovascular death at one year
Freedom from aortic valve or root reoperation at one year
Median overall CXT and isolated root CXT during surgery
The KONECT RESILIA aortic valved conduit offers a simplified approach to root replacement, with excellent short-term outcomes reported through one year.
Single-center retrospective study of adults undergoing elective bio-Bentall procedures with KONECT RESILIA aortic valved conduit2
Study site
Yale School of Medicine, Division of Cardiac Surgery
Number of patients
118 patients
Study years
2021-2023
Low operative and short-term mortality
Median length of stay: 6.5 days
Initial findings suggest the KONECT RESILIA aortic valved conduit may offer favorable early outcomes for patients undergoing aortic root and valve replacement.
RESILIA tissue data from the COMMENCE aortic trial show*
Proven performance at 7 years
Freedom from all-cause mortality through 7 years
Freedom from structural valve deterioration through 7 years
Clinically stable hemodynamics
*Clinical data on surgical valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up to 10-years in progress.3